F A Sirgel - Concepedia

Author

F A Sirgel

Also Known As

F A Sirgel, F Sirgel, F. A. SIRGEL, F. A. Sirgel, F. Sirgel, F.A. SIRGEL, F.A. Sirgel, FA Sirgel, Frik A Sirgel, Frik A. Sirgel

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Stellenbosch University South African Medical Research Council University of Cape Town Tygerberg Hospital London School of Hygiene & Tropical Medicine

About

F A Sirgel is an author at Stellenbosch University specializing in tuberculosis, microbiology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	4	4	548
2	Medicine	4	4	548
3	Microbiology	4	4	548
4	Epidemiology	1	1	33
5	Pathology	1	1	39

F A Sirgel

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis Francesc Coll, Jody Phelan, Grant Hill-Cawthorne, Nature Genetics Pulmonary TuberculosisAntimicrobial Resistance GeneHealth SciencesTuberculosis PreventionTuberculosis	2018	421
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Roxana Rustomjee, Christian Lienhardt, Thomas P. Kanyok, PubMed	2008	284
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13 Anup Aggarwal, Maloy Kumar Parai, N.D. Shetty, Cell	2017	180
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs F A Sirgel, P. R. Donald, Joseph Odhiambo, Journal of Antimicrobial Chemotherapy	2000	109
The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis F A Sirgel, P. Bernard Fourie, Peter R. Donald, American Journal of Respiratory and Critical Care Medicine	2005	104
The Influence of Human N-Acetyltransferase Genotype on the Early Bactericidal Activity of Isoniazid Peter R. Donald, F A Sirgel, Amour Venter, Clinical Infectious Diseases	2004	89
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study Brigitta Derendinger, Anzaan Dippenaar, Margaretha de Vos, The Lancet Microbe	2023	89
Primary drug-resistant tuberculosis in children. H. Simon Schaaf, Robert P. Gie, Nulda Beyers, PubMed	2000	71
Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare G S Pretorius, Paul D. van Helden, F A Sirgel, Antimicrobial Agents and Chemotherapy	1995	57
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. F J Botha, F A Sirgel, D. P. Parkin, PubMed Antimicrobial ChemotherapyDrug ResistanceMedical MicrobiologyM. TuberculosisMycobacterium Tuberculosis	1996	55

Page 1